Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination
| Autor: | Krisly Arguedas Vásquez, Daniel Valerio Aguilar, Henri-Jacques Hernández Gabarain, Erick Miranda Valverde |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Screening test Cognitive Neuroscience Disease lcsh:RC321-571 03 medical and health sciences mild cognitive impairment 0302 clinical medicine medicine comprometimento cognitivo In patient Cognitive impairment lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry cognitive impairment 030304 developmental biology Cognitive evaluation theory 0303 health sciences Mini–Mental State Examination medicine.diagnostic_test comprometimento cognitivo leve business.industry Montreal Cognitive Assessment Cognition Sensory Systems doença de Parkinson Neurology Parkinson’s disease Physical therapy Original Article Neurology (clinical) Geriatrics and Gerontology business 030217 neurology & neurosurgery |
| Zdroj: | Dementia & Neuropsychologia, Vol 13, Iss 1, Pp 78-81 Dementia & Neuropsychologia, Volume: 13, Issue: 1, Pages: 78-81, Published: MAR 2019 Dementia & Neuropsychologia v.13 n.1 2019 Dementia & Neuropsychologia Associação de Neurologia Cognitiva e do Comportamento (ANCC) instacron:ANCC |
| ISSN: | 1980-5764 |
| DOI: | 10.1590/1980-57642018dn13-010008 |
| Popis: | Several screening tests have been used for cognitive evaluation in Parkinson’s disease (PD). Objective: To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease and no cognitive impairment complaints. Methods: A total of 40 PD patients with no complaints of cognitive problems were included. Patients were selected using the Mini-Mental State Examination (MMSE) and the MoCA was then administered. Results: 80% of patients exhibited Mild Cognitive Impairment (MCI) according to the MoCA. Statistically significant differences in visuospatial, attention and delayed recall functions were evident between the normal and abnormal MoCA groups. Conclusion: The study results suggest that MoCA may be a good screening test in patients with PD who do not present cognitive complaints. RESUMO: Vários testes de triagem foram utilizados para avaliação cognitiva na doença de Parkinson (DP). Objetivo: Avaliar a utilidade da Avaliação Cognitiva de Montreal (MoCA) em pacientes com doença de Parkinson sem queixa de comprometimento cognitivo. Métodos: Um total de 40 pacientes com TP sem queixas de problemas cognitivos foram admitidos e com o Estado de Exame do Estado Mental Mini (MEEM) foram selecionados e receberam o MoCA. Resultados: 80% apresentaram dados de Comprometimento Cognitivo Leve (ICM) segundo o MoCA, sendo as funções visoespaciais, atenção e memória atrasada aquelas que apresentaram diferenças estatisticamente significantes entre os grupos MoCA normal e anormal. Conclusão: Este estudo sugere que o MoCA pode ser um bom teste de triagem em pacientes com DP que não apresentam queixas cognitivas. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|